MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0090108
Olympus Therapeutics Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.9 Cr
▲ 3% YoY
Net loss · FY 2025
₹9.14 Lakh
Net margin -0.5%
EBITDA · FY 2025
₹3.31 Cr
EBITDA margin 19.6%
Authorised capital
₹99 Lakh
Registered with MCA
Paid-up capital
₹73.92 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Employees · EPFO
128
Provident fund records
About Olympus Therapeutics Private Limited
Data last updated:
Olympus Therapeutics Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24290TN2015PTC101114. Its GSTIN is 33AACCO1613L1ZP (Tamil Nadu).
The company has an authorised share capital of ₹99 Lakh and a paid-up capital of ₹73.92 Lakh. It is led by directors including Ravichandran Venkatraman and Krishnamurthymani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.31 Balaji Nagar 5th Cross Street Ekkatuthangal, Chennai, Tamil Nadu, India – 600032.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.9 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹9.14 Lakh (net margin -0.5%) and EBITDA of ₹3.31 Cr (EBITDA margin 19.6%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 7% over five years.
The company has about 128 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Olympus Therapeutics. As per MCA filings, the company has open charges of ₹2 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹6.9 Cr; the latest was in August 2016. Its 5 peer companies in the Pharma industry (Healthcare Products, Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 3 smaller; the largest is Kaushal Healthcare Private Limited with revenue of ₹17.1 Cr. The company has 4 MSME Form 1 returns on record between 2021 and 2023, listing 98 overdue payments to 12 micro and small suppliers.
Olympus Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0090108). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website olympuspharma.com.
Company details
CIN U24290TN2015PTC101114
Registration Number 101114
Incorporation Date 24 June 2015
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0090108
Key People
Ravichandran Venkatraman Director Krishnamurthymani Director Ganapathy Pallavur Jayaram Additional Director Recognitions & Rankings of Olympus Therapeutics
Contact details
Olympus Therapeutics Private Limited's registered office is in Chennai, Tamil Nadu. Its website is olympuspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.31 Balaji Nagar 5th Cross Street Ekkatuthangal, Chennai, Tamil Nadu, India – 600032
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Olympus Therapeutics Private Limited, buy the company report.
Comprehensive company report
Olympus Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Olympus Therapeutics operates one associated brand: Olympus Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and promotes pharmaceutical products for fertility, orthopedics, and general health issues. | olympuspharma.com |
Business activity
The main business activity of Olympus Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Olympus Therapeutics Private Limited, buy the company report.
Financials of Olympus Therapeutics Private Limited
FY 2025 filings availableOlympus Therapeutics Private Limited reported revenue of ₹16.9 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹16.9 Cr ▲ 3%
Net loss · FY 2025
₹9.14 Lakh margin -0.5%
EBITDA · FY 2025
₹3.31 Cr margin 19.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 8%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 3%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 3% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹16.9 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.6% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Olympus Therapeutics Private Limited, buy the company report.
Board of directors of Olympus Therapeutics Private Limited
Olympus Therapeutics has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravichandran Venkatraman | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
| Krishnamurthymani | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
| Ganapathy Pallavur Jayaram Also directs: Indus Life Sciences Private Limited | Additional Director | 03 Jun 2026 | 0 Years 5 Months | Current |
Peer comparison
Olympus Therapeutics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Healthcare Products, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kaushal Healthcare Private Limited | ₹17.1 Cr (FY 2024) | -23.0% | Kolkata, West Bengal, India | |||
| Shri Imaging and X-Ray Films Private Limited | ₹17 Cr (FY 2025) | -11.0% | Chandigarh, India | |||
| Olympus Therapeutics Private Limitedthis company | ₹16.9 Cr (FY 2025) | -₹9.14 Lakh | -0.5% | 3.0% | 128 | Chennai, Tamil Nadu, India |
| Starlex Health Services and Products Private Limited | ₹16.89 Cr (FY 2025) | -3.0% | Perinthalmanna, Kerala, India | |||
| Pharmacheck Impex Private Limited | ₹16.87 Cr (FY 2025) | 63.0% | Nagpur, Maharashtra, India | |||
| Mahaswaan Pharma Private Limited | ₹16.83 Cr (FY 2024) | -35.0% | New Delhi, Delhi, India |
To see the full peer comparison of Olympus Therapeutics Private Limited, buy the company report.
Auditor
Olympus Therapeutics Private Limited is audited by AR.ANNAMALAI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AR.ANNAMALAI & CO | FY 2023 | 028036 |
Shareholding
The shareholding of Olympus Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Olympus Therapeutics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Feb 2024 | 100890048 | Others | ₹1 Cr | Open | |
| 14 Jun 2023 | 100789207 | Hdfc Bank Limited | ₹1 Cr | Open |
Total charge records: 2 View all charges
Deals & funding
Olympus Therapeutics Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹6.9 Cr; the latest was in August 2016.
Total deals
1
Funding round
1
Disclosed funding
₹6.9 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2016 | Funding round | ₹6.9 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Olympus Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Olympus Therapeutics Private Limited has 4 MSME Form 1 returns on record between 2021 and 2023, listing 98 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Elista Pharmaceuticals | |||
| Goodman Pharmaceuticals | |||
| Kausikh Therapeutics Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Olympus Therapeutics Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Olympus Therapeutics Private Limited has a workforce of 128 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
128
Active EPFO establishments
1
Employee growth
1.59%
GST
Olympus Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCO1613L1ZP | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Olympus Therapeutics Private Limited, buy the company report.
Recent activity
Olympus Therapeutics Private Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Ganapathy Pallavur Jayaram was appointed as Additional Director on 03 Jun 2026.
Appointed
Ganapathy Pallavur Jayaram was appointed as Additional Director.
AGM
Olympus Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Olympus Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Karnnanidhi Venneela Ramanar ceased to be Director.
Appointed
Krishnamurthymani was appointed as Director.
Appointed
Ravichandran Venkatraman was appointed as Director.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100890048 was registered on 02 Feb 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 100789207 was registered on 14 Jun 2023.
Ceased
Venkataraghavan Sourirajan ceased to be Director.
Ceased
Sekaripuram Anantaraman Manikandan ceased to be Additional Director.
Ceased
Latha Subramanian ceased to be Additional Director.
Incorporation
24 Jun 2015
Olympus Therapeutics Private Limited was registered on 24 Jun 2015 with Roc Chennai & aged 11 years 4 months as per MCA records.
Frequently asked questions
Olympus Therapeutics is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 June 2015 (11+ years old) and is registered under CIN U24290TN2015PTC101114.
Olympus Therapeutics has 3 current directors:
- Ravichandran Venkatraman - Director
- Krishnamurthymani - Director
- Ganapathy Pallavur Jayaram - Additional Director
The latest financial statements of Olympus Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Olympus Therapeutics is 33AACCO1613L1ZP, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Olympus Therapeutics is U24290TN2015PTC101114. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Olympus Therapeutics was incorporated on 24 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
Olympus Therapeutics has 1 deal on record (1 funding round), with disclosed funding of ₹6.9 Cr; the latest was in August 2016.
The peers of Olympus Therapeutics by revenue are Kaushal Healthcare Private Limited, Shri Imaging and X-Ray Films Private Limited, Starlex Health Services and Products Private Limited, Pharmacheck Impex Private Limited, Mahaswaan Pharma Private Limited, all in the Pharma industry (Healthcare Products, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ganapathy Pallavur Jayaram was appointed as Additional Director on 03 Jun 2026. Karnnanidhi Venneela Ramanar ceased to be Director on 20 Mar 2025. Krishnamurthymani was appointed as Director on 20 Mar 2025. Olympus Therapeutics has 7 board changes on record in total.
Yes, Olympus Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0090108).
Olympus Therapeutics has 4 MSME Form 1 returns on record between 2021 and 2023, listing 98 overdue payments to 12 micro and small suppliers. The latest return was filed on 29 Aug 2023.
Olympus Therapeutics can be reached through the website olympuspharma.com. Its registered office is in Chennai, Tamil Nadu, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages